期刊文献+

高频电汽化切除并注射THP治疗浅表膀胱癌18例 被引量:3

Transurethral Electro-Vaporization Combined with Mucomembranous and Intravesical Administration or THP for the Treatment of Superficial Bladder Tumor (Report of 18 Cases)
下载PDF
导出
摘要 目的 :探讨高频电汽化切除后粘膜下注射及膀胱内灌注抗癌药物治疗浅表膀胱肿瘤的效果。方法 :经尿道高频电汽化膀胱肿瘤、肿瘤周围粘膜下和基底部注射盐酸吡柔比星 (THP) ,术后间断膀胱内灌注THP。结果 :本组 18例浅表膀胱肿瘤 ,术中、术后均无输血 ,无膀膀穿孔 ,未引起组织坏死。术后随访 (6 - 15 )月 ,未引起骨髓抑制 ,未见肿瘤复发。结论 :此方法操作简单、安全、恢复快 ,并发症低。粘膜下注射并膀胱内灌注抗癌药物重点部位突出 ,药液扩散均匀 ,既可杀灭存留的肿瘤细胞 ,又对微小癌灶产生毒性作用 。 Objective:To investigate the effect of transurethral electro-vaporization combined with muconembranous and intravesical administration of piraubicin hydrochloride (THP) for the treatment of bladder tumor.Methods:The tumor were ablated by transurethral electro-vaporiztation ,and then THP were inject into mucomymb around tumors.After operation operation,THP were perfused into urinary bladder cavity periodically results the operations were successful in all 18 cases of bladder without transfusion and vesical perforation Tumor did not recurrence and depressed marrow were not found in all cases in following6-15 months.Conclusion:THP could destroy the rudimental cells of tumor by mucomim branous and intravesical administration completely Transuerthral electro-vaporization combined with mucomembranous and intravesical administration of THP was effective on bodder tumor,characterized by simplify and less complicution.\;
作者 孙恒信
出处 《河南职工医学院学报》 2001年第2期123-124,共2页 Journal of Henan Medical College For Staff and Workers
关键词 膀胱肿瘤 抗癌药 注射疗法 电汽化切除术 THP 盐酸吡柔比星 transurethral electro-vaporization bladder tumor administration of THP
  • 相关文献

参考文献3

二级参考文献3

共引文献14

同被引文献23

  • 1邓建华,白进良,张石生,马鹏程,万江厚.α-干扰素加吡柔比星灌注化疗对预防膀胱癌术后复发的疗效[J].癌症,2004,23(7):839-841. 被引量:9
  • 2吴荣扬,彭善友.膀胱粘膜下注射抗癌药物的实验研究与临床观察[J].中华泌尿外科杂志,1993,14(2):108-110. 被引量:40
  • 3Nishisaka N, Wada S, Ikemoto S, et al. The effectiveness of neoadjnvent chemotherapy for invasive bladder cancer[ J ]. Nippon Hinyokika Gakkai Zasshi, 1996,87:1250-1257.
  • 4Takashima S, Nakamura K, Nakatsuka H,et al. Means of effective and practical intra-arterial chemotherapy for locally invasive bladder cancer with special reference to clinical analysis of bladder cancer patients treated by intermittent intra-arterical infusion using an implantable port system[J]. Hinyodika-kiyo, 1999,45 : 127-131.
  • 5Sumiyoshi Y, Hashine K, Nakatsuji H. Intra-arterial chemotherapy in combination with radiotherapy for invasive bladder cancer and prostate cancer[J]. Hinyokika-kiyo, 1999,45:155-158.
  • 6Hoshi S, Mao H, Takahashi T, et al. Internal iliac arterial infusion chemotherapy for rabbit invasive bladder cancer[J]. Int J Urol, 1997,4:493-499.
  • 7Mizutani Y, yoshida O, miki T, et al. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells[J]. Clin Cancer Res, 1999,5:2605-2612.
  • 8Kawamora S, Fujioka T. A course of pirarubicin vesical irrigation at thirty mg effectively prevents post-TUR recurrence of superficial bladder cancer[J]. Gan To Kagaku Ryoho, 1996,23:465-470.
  • 9Kobayashi M,Sugays Y, Yuzawa M,et al. Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue , antitumor effect and side effect in intravesical instillation therapy for bladder tumor[J]. Gan To Kagaku Ryoho, 1998,25: 1771-1774.
  • 10Nakagawa S, Kojima M,Takada H, et al. Short duration bladder instillation therapy with pirarubicin for superficial bladder tumor based on pharmacodynamic study. Gan to kagaku Ryoho,1992,19(11) :1873- 7.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部